Heart Failure in the Elderly: The Unseen Mechanisms of a Growing Epidemic
A comprehensive review in the European Heart Journal examines the unique epidemiology and pathophysiology of heart failure in the elderly, who constitute the majority of patients. While the lifetime risk of developing heart failure is about 25%, incidence spikes sharply after age 70. The article details how biological ageing processes—including impaired autophagy, mitochondrial dysfunction, cellular senescence, and chronic low-grade inflammation (“inflammaging”)—compromise cardiac energy and promote cell dysfunction, increasing HF risk. It notes that these specific ageing-related mechanisms are not yet targeted by current guideline-recommended therapies, which remain the cornerstone of treatment but are often complicated by comorbidities, frailty, and low blood pressure in this population.
Why it might matter to you:
This review provides a crucial pathophysiological framework for understanding a condition you will frequently encounter in clinical practice, especially in acute care settings. It highlights the gap between standard evidence-based therapy and the specific biological drivers of disease in the elderly, which is essential knowledge for nuanced clinical decision-making. Understanding these mechanisms can inform more tailored patient management and future therapeutic strategies.
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
